A unidirectional porous beta-tricalcium phosphate material (Affinos®) for reconstruction of bony defects after excision of fibular bone for spinal surgery graft.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 29 03 2019
accepted: 22 05 2019
pubmed: 9 6 2019
medline: 16 10 2019
entrez: 9 6 2019
Statut: ppublish

Résumé

The aim of this study was to elucidate the bone regeneration-inducing capability of Affinos®, a newly developed, high-porosity unidirectional porous β-TCP artificial bone. We compared the ability of Affinos® and OSferion®, a commercially available β-TCP product, to induce bone regeneration following implantation into bony defects left after fibula harvesting for spinal fusion surgery. Study subjects underwent surgery to harvest non-vascularized fibula grafts for spinal fusion surgery and were implanted with either Affinos® (19 patients) or OSferion® (15 patients, control group) at the defect site. The minimal and mean follow up periods were 6 and 11 months after surgery, respectively. X-rays of the lower leg taken 1-2 weeks after surgery and at the final follow-up visit were used to evaluate fibular-β-TCP continuity and fibula defect filling ratio. There was no significant difference in radiographic continuity in the fibula between the two groups. The fibula defect filling ratio for the Affinos® group decreased from 0.94 ± 0.17 at 1-2 weeks to 0.77 ± 0.14 at 10 months. For the OSferion® control group, the fibula defect filling ratio decreased from 0.94 ± 0.14 at 1-2 weeks to 0.52 ± 0.27 at final follow-up. The Affinos® group showed a significantly higher fibula defect filling ratio compared to that for the OSferion® group (p = 0.003). These results indicate that Affinos® has slow absorption rates and significant defect filling activity compared with OSferion®. Thus, Affinos® could be a suitable substitute to fill bony defects induced by fibula harvesting for spinal reconstruction surgery.

Identifiants

pubmed: 31174946
pii: S0967-5868(19)30638-1
doi: 10.1016/j.jocn.2019.05.021
pii:
doi:

Substances chimiques

Calcium Phosphates 0
beta-tricalcium phosphate 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-76

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Hiroshi Noguchi (H)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan. Electronic address: noguhiro0164@tsukuba-seikei.jp.

Toru Funayama (T)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Masao Koda (M)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Yasushi Iijima (Y)

Department of Orthopedic Surgery, Seirei Sakura Citizen Hospital, Chiba, Japan.

Hiroshi Kumagai (H)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Tetsuhiro Ishikawa (T)

Department of Orthopedic Surgery, Sanmu Medical Center, Chiba, Japan.

Atsuomi Aiba (A)

Department of Orthopedic Surgery, Numazu City Hospital, Shizuoka, Japan.

Tetsuya Abe (T)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Katsuya Nagashima (K)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Kousei Miura (K)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Shigeo Izawa (S)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Satoshi Maki (S)

Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Takeo Furuya (T)

Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Masashi Yamazaki (M)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH